Global and United States Synthetic Biology Technology Market Report & Forecast 2022-2028

Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
Market Analysis and Insights: Global and United States Synthetic Biology Technology Market
This report focuses on global and United States Synthetic Biology Technology market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Synthetic Biology Technology market size is estimated to be worth US$ 1490.5 million in 2022 and is forecast to a readjusted size of US$ 4085.5 million by 2028 with a CAGR of 18.3% during the review period. Fully considering the economic change by this health crisis, by Type, Gene Synthesis accounting for % of the Synthetic Biology Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Medicine was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The North American market is the most important consumer region, accounting for 48.23% of the global total in 2019, with sales of US$421.30 million. The European market is second only to the North American market, accounting for 21.12% of the global total, with sales of US$184.52 million. The leading products represented by Genscript Biotech, Integrated DNA, Ginkgo Bioworks, Agilent, Thermo Fisher, etc. occupy a leading position in the international market, accounting for 45.54% of the global market share.
Global Synthetic Biology Technology Scope and Market Size
Synthetic Biology Technology market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Synthetic Biology Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Synthetic Biology Technology market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Gene Synthesis
Oligonucleotide Synthesis
Bioinformatics Analysis
DNA Assembly
Segment by Application
Medicine
Chemical Industry
Agriculture
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Genscript Biotech
Integrated DNA
Ginkgo Bioworks
Agilent
Thermo Fisher
BBI
Eurofins Genomics
Genewiz
Synthetic Genomics
Twist Bioscience
SBS Genetech
ATUM